The biggest selling pharmaceutical product in the history of the world is Humira (adalimumab). AbbVie Inc.’s antirheumatic has racked up nearly $220bn in cumulative revenues since its market debut in 2003, and despite generic competition is forecast to sell another $46bn out to 2028, according to sellside consensus compiled by Evaluate Pharma.
Key Takeaways
- An analysis of past and forecast future sales shows AbbVie’s Humira in the lead with a total of nearly $220bn
But another product could, in time, leave Humira in the dust. Some analysts are forecasting peak annual sales for Zepbound...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
